Formaldehyde structure
|
Common Name | Formaldehyde | ||
|---|---|---|---|---|
| CAS Number | 50-00-0 | Molecular Weight | 30.026 | |
| Density | 0.7±0.1 g/cm3 | Boiling Point | -19.5±9.0 °C at 760 mmHg | |
| Molecular Formula | CH2O | Melting Point | -92 °C | |
| MSDS | Chinese USA | Flash Point | -75.1±13.7 °C | |
| Symbol |
GHS05, GHS06, GHS08 |
Signal Word | Danger | |
| Name | Formaldehyde |
|---|---|
| Synonym | More Synonyms |
| Density | 0.7±0.1 g/cm3 |
|---|---|
| Boiling Point | -19.5±9.0 °C at 760 mmHg |
| Melting Point | -92 °C |
| Molecular Formula | CH2O |
| Molecular Weight | 30.026 |
| Flash Point | -75.1±13.7 °C |
| Exact Mass | 30.010565 |
| PSA | 17.07000 |
| LogP | 0.35 |
| Vapour density | 白色晶体 |
| Vapour Pressure | 3463.8±0.0 mmHg at 25°C |
| Index of Refraction | 1.235 |
| InChIKey | WSFSSNUMVMOOMR-UHFFFAOYSA-N |
| SMILES | C=O |
| Symbol |
GHS05, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 + H311 + H331-H314-H317-H335-H341-H350-H370 |
| Precautionary Statements | P201-P260-P280-P301 + P310 + P330-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338-P308 + P311-P403 + P233 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | T;C |
| Risk Phrases | R23/24/25;R34;R43;R45 |
| Safety Phrases | S26;S36/37/39;S45;S51;S53;S60 |
| RIDADR | III |
| WGK Germany | 7 g/L (25 ºC) |
| RTECS | LP8925000 |
| Packaging Group | 8 |
| Hazard Class | S26;S36/37/39;S45;S51;S53;S60 |
| HS Code | 2912110000 |
| Precursor 0 | |
|---|---|
| DownStream 10 | |
| HS Code | 2912110000 |
|---|
|
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.
Nat. Commun. 6 , 5794, (2015) Early T-cell precursor leukaemia (ETP-ALL) is a high-risk subtype of human leukaemia that is poorly understood at the molecular level. Here we report translocations targeting the zinc finger E-box-bin... |
|
|
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
Biomaterials 51 , 1-11, (2015) Targeting cancer metabolism is emerging as a successful strategy for cancer therapy. However, most of the marketed anti-metabolism drugs in cancer therapy do not distinguish normal cells from cancer c... |
|
|
BBS4 directly affects proliferation and differentiation of adipocytes.
Cell. Mol. Life Sci. 71(17) , 3381-92, (2014) BBS4 is one of several proteins whose defects cause Bardet-Biedl syndrome (BBS), a multi-systemic disorder, manifesting with marked obesity. BBS4 polymorphisms have been associated with common non-syn... |
| superlysoform |
| HCHO |
| Formol |
| Methylene glycol |
| Formalin |
| Oxomethylene |
| Morbicid |
| Methanal |
| Formaldehyde |
| MFCD00003274 |
| Oxymethylene |
| Oxomethane |
| EINECS 200-001-8 |
| VHH |
| lysoform |
| formalith |
| Methyl aldehyde |
| CH2O |
| Methylene oxide |
| fannoform |
| Formic aldehyde |